Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA
- PMID: 1433526
- PMCID: PMC240455
- DOI: 10.1128/JVI.66.12.7469-7480.1992
Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA
Abstract
The posttranscriptional trans activation of unspliced or partially spliced human immunodeficiency virus RNAs by the Rev regulatory protein is crucial for virus replication and is dependent on sequence-specific RNA binding by Rev. The cognate RNA target of Rev is contained within a highly structured, 244-nucleotide Rev-responsive element (RRE) RNA in the viral env gene. Here, we show that specific interaction with the RRE is not an absolute requirement for Rev function. When the RRE is replaced by a heterologous MS2 phage operator sequence, Rev will facilitate the cytoplasmic expression of human immunodeficiency virus mRNAs containing this sequence if directed to the MS2 operator via the RNA binding motif of the MS2 phage coat protein (MS-C) as a Rev/MS-C fusion protein. Rev/MS-C efficiently activated both RRE and MS2 targets. A mutation in the MS2 operator that abolished the coat protein binding in vitro rendered the mutant RNA nonresponsive to the fusion protein in vivo. Notwithstanding that Rev can be tethered to the viral RNAs via another RNA binding motif, the structural integrity of the N terminus of Rev was still required for optimal trans activation.
Similar articles
-
Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.J Virol. 2001 Mar;75(6):2957-71. doi: 10.1128/JVI.75.6.2957-2971.2001. J Virol. 2001. PMID: 11222721 Free PMC article.
-
Posttranscriptional regulation by the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex proteins through a heterologous RNA binding site.J Virol. 1992 Dec;66(12):7232-8. doi: 10.1128/JVI.66.12.7232-7238.1992. J Virol. 1992. PMID: 1433516 Free PMC article.
-
The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.Genes Dev. 1992 Nov;6(11):2077-87. doi: 10.1101/gad.6.11.2077. Genes Dev. 1992. PMID: 1427073
-
Rev-dependent expression of three species of HIV-1 mRNAs (review).Int J Mol Med. 1999 Mar;3(3):297-302. doi: 10.3892/ijmm.3.3.297. Int J Mol Med. 1999. PMID: 10028055 Review.
-
Regulation of expression of human immunodeficiency virus.New Biol. 1990 Jan;2(1):20-31. New Biol. 1990. PMID: 2078551 Review.
Cited by
-
Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domains.PLoS One. 2012;7(6):e38305. doi: 10.1371/journal.pone.0038305. Epub 2012 Jun 4. PLoS One. 2012. PMID: 22675540 Free PMC article.
-
The HIV-1 Rev response element: an RNA scaffold that directs the cooperative assembly of a homo-oligomeric ribonucleoprotein complex.RNA Biol. 2012 Jan;9(1):6-11. doi: 10.4161/rna.9.1.18178. Epub 2012 Jan 1. RNA Biol. 2012. PMID: 22258145 Free PMC article.
-
Inhibition of human immunodeficiency virus type 1 Rev function by a dominant-negative mutant of Sam68 through sequestration of unspliced RNA at perinuclear bundles.J Virol. 2001 Sep;75(17):8203-15. doi: 10.1128/jvi.75.17.8203-8215.2001. J Virol. 2001. PMID: 11483766 Free PMC article.
-
Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.J Virol. 2001 Mar;75(6):2957-71. doi: 10.1128/JVI.75.6.2957-2971.2001. J Virol. 2001. PMID: 11222721 Free PMC article.
-
Cellular protein modulates effects of human immunodeficiency virus type 1 Rev.J Virol. 1994 Jun;68(6):3850-6. doi: 10.1128/JVI.68.6.3850-3856.1994. J Virol. 1994. PMID: 8189522 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources